Get informed when a big investor buys or sells
+ FollowOvervalued by 52.7% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $2.60 Billion |
|---|---|
| Enterprise Value | $2.16 Billion |
| Annual dividend | $2.34 |
| Earnings per Share | $1.47 |
| Beta | 1.73 |
| Outstanding Shares | 41,009,000 |
| P/E Ratio | 88.55 |
|---|---|
| PEG | 49.51 |
| Price to Sales | 2.53 |
| Price to Book Ratio | 1.62 |
| Enterprise Value to Revenue | 2.1 |
| Enterprise Value to EBIT | 21.31 |
| Enterprise Value to Net Income | 34 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.17 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers ('OEMs') a competitive advantage. Novanta combines deep proprietary technology expertise and com...
Stockcircle shows 5 open-market insider sales for Novanta Tangible Equity Units in the last six months from SEC Form 4 reports by executives, directors, and other insiders.
Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.